跳至主要内容
临床试验/IRCT20120718010324N75
IRCT20120718010324N75招募中3 期

The effect of magnesium on depression and sleep quality and quality of life in postmenopausal women: a randomized controlled trial

Tabriz University of Medical Sciences0 个研究点目标入组 82 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
82

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 60 years(—)
性别
Female

入选标准

  • Women who are 45 to 60 years old.
  • At least one year has passed since their last period.
  • Mild and moderate depression based on the Beck questionnaire (score 14 to 28)
  • Diagnosis of inappropriate sleep quality based on the Pittsburgh questionnaire (scores 6 to 21)

排除标准

  • Having other psychotic disorders such as schizophrenia and active delusions ,Insanity, Bipolar disease, Dementia according to the person's self-report or medical record
  • Regular use of supplements and minerals, especially magnesium, in the last few months
  • Having diseases such as kidney disease (the active role of the kidney in magnesium homeostasis) and myasthenia gravis (due to the aggravation of the disease by magnesium) and gastrointestinal disease (diarrhea is a common side effect of magnesium) according to the individual's statement or the medical record.
  • Planned surgery within the next three months (due to the incomplete continuation of the treatment process)
  • Using drugs that interfere with magnesium (drugs such as Eltrombopag, Baloxavir, Tetracycline, Marboxil, Demeclocycline, Doxycycline, Minocycline, Oxytetracycline)
  • The existence of recent crises in life

研究者

相似试验